003020 立方製藥
按盤價 
21.740 -0.340 (-1.540%)
21.740 -0.340 (-1.540%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.932 | 9.315 | 9.382 | 14.322 | 15.033 |
| 總資產報酬率 ROA (%) | 1.348 | 6.388 | 6.336 | 9.844 | 11.025 |
| 投入資產回報率 ROIC (%) | 1.838 | 8.901 | 8.991 | 12.952 | 13.104 | 邊際利潤分析 |
| 銷售毛利率 (%) | 65.860 | 64.551 | 69.161 | 51.483 | 37.385 |
| 營業利潤率 (%) | 11.705 | 11.720 | 11.705 | 13.430 | 9.307 |
| 息稅前利潤/營業總收入 (%) | 11.620 | 11.738 | 11.300 | 13.369 | 9.160 |
| 淨利潤/營業總收入 (%) | 9.874 | 10.526 | 10.042 | 12.304 | 8.112 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.127 | 78.339 | 94.588 | 84.758 | 84.453 |
| 價值變動淨收益/利潤總額(%) | -1.576 | 15.329 | 7.568 | 10.800 | 13.449 |
| 營業外收支淨額/利潤總額(%) | -1.182 | -0.171 | -3.445 | 0.834 | -0.097 | 償債能力分析 |
| 流動比率 (X) | 2.281 | 2.259 | 2.037 | 2.121 | 2.333 |
| 速動比率 (X) | 1.861 | 1.867 | 1.658 | 1.673 | 1.752 |
| 資產負債率 (%) | 25.026 | 24.526 | 26.040 | 24.568 | 30.241 |
| 帶息債務/全部投入資本 (%) | 2.883 | 1.318 | 2.988 | 1.493 | 14.462 |
| 股東權益/帶息債務 (%) | 3,277.462 | 7,272.968 | 3,188.495 | 6,459.033 | 584.027 |
| 股東權益/負債合計 (%) | 278.078 | 285.235 | 258.085 | 276.234 | 230.675 |
| 利息保障倍數 (X) | 225.757 | 311.052 | -758.353 | -77.149 | -66.620 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 111.802 | 95.162 | 74.380 | 54.865 | 42.121 |
| 存貨周轉天數 (天) | 159.506 | 138.881 | 178.119 | 118.024 | 61.367 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
